Home › Funds › ORBIMED ADVISORS LLC › JAZZ
ORBIMED ADVISORS LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
ORBIMED ADVISORS LLC reported holding 131,100 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$30.4M, representing 0.62% of its reported portfolio and ranking #39 among its reported holdings. ORBIMED ADVISORS LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's JAZZ position evolved
ORBIMED ADVISORS LLC first disclosed a stake in JAZZ in Q3 2026 at 131,100 shares (US$30.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 131.10K | $30.35M | New |
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 41 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), Boston Trust Walden Corp (US$98.3M), Sofinnova Investments, Inc. (US$97.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.40M sh · $323.77M · Q3 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
- Sofinnova Investments, Inc. 422.38K sh · $97.79M · Q3 2026
- GOLDENTREE ASSET MANAGEMENT LP 421.94K sh · $97.55M · Q3 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held JAZZ?
ORBIMED ADVISORS LLC has disclosed JAZZ holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ORBIMED ADVISORS LLC's current position in JAZZ?
As of Q3 2026, ORBIMED ADVISORS LLC holds 131.10K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $30.35M, representing 0.62% of its reported portfolio and ranking #39.
Has ORBIMED ADVISORS LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), ORBIMED ADVISORS LLC newly opened its position in JAZZ.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., Boston Trust Walden Corp, Sofinnova Investments, Inc., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.